Roivant Sciences is a biopharmaceutical company that focuses on developing and commercializing innovative therapies to address unmet medical needs. They specialize in identifying and acquiring promising drug candidates from other companies and advancing them through clinical trials and regulatory approval processes.

In terms of the stock trend, Roivant Sciences is currently basing in the context of an uptrend. Basing refers to a period of consolidation and sideways movement after a significant upward move. This consolidation phase allows the stock to build a strong foundation before potentially resuming its upward trajectory.

Investors should closely monitor the stock's price action and volume during this basing period. A breakout above the consolidation range could signal a continuation of the uptrend and present potential buying opportunities. However, it is important to conduct thorough analysis and consider other factors before making any investment decisions.